Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy

Animesh Tandon, Chet R. Villa, Kan N. Hor, John L. Jefferies, Zhiqian Gao, Jeffrey A. Towbin, Brenda L. Wong, Wojciech Mazur, Robert J. Fleck, Joshua J. Sticka, D. Woodrow Benson, Michael D. Taylor

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background-Patients with Duchenne muscular dystrophy exhibit progressive cardiac and skeletal muscle dysfunction. Based onprior data, cardiac dysfunction in Duchenne muscular dystrophy patients may be influenced by myocardial fibrosis and steroidtherapy. We examined the longitudinal relationship of myocardial fibrosis and ventricular dysfunction using cardiac magneticresonance in a large Duchenne muscular dystrophy cohort.Methods and Results-We reviewed 465 serial cardiac magnetic resonance studies (98 Duchenne muscular dystrophy patientswith 7≥4 cardiac magnetic resonance studies) for left ventricular ejection fraction (LVEF) and presence of late gadoliniumenhancement (LGE), a marker for myocardial fibrosis. LVEF was modeled by examining LGE status, myocardial fibrosis burden (asassessed by the number of LGE-positive left ventricular segments), patient age, and steroid treatment duration. An age-only modeldemonstrated that LVEF declined 0.58±0.10% per year. In patients with both LGE-negative and LGE-positive studies (n=51), LVEFdid not decline significantly over time if LGE was absent but declined 2.2±0.31% per year when LGE was present. Univariatemodeling showed significant associations between LVEF and steroid treatment duration, presence of LGE, and number of LGEpositiveleft ventricular segments; multivariate modeling showed that LVEF declined by 0.93±0.09% for each LGE-positive leftventricular segment, whereas age and steroid treatment duration were not significant. The number of LGE-positive left ventricularsegments increased with age, and longer steroid treatment duration was associated with lower age-related increases.Conclusion-Progressive myocardial fibrosis, as detected by LGE, was strongly correlated with the LVEF decline in Duchennemuscular dystrophy patients. Longer steroid treatment duration was associated with a lower age-related increase in myocardialfibrosis burden.

Original languageEnglish (US)
Article numbere001338
JournalJournal of the American Heart Association
Volume4
Issue number4
DOIs
StatePublished - Jan 1 2015

Fingerprint

Duchenne Muscular Dystrophy
Stroke Volume
Fibrosis
Steroids
Magnetic Resonance Spectroscopy
Therapeutics
Ventricular Dysfunction
Myocardium
Skeletal Muscle

Keywords

  • Cardiomyopathy
  • Magnetic resonance imaging
  • Morbidity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy. / Tandon, Animesh; Villa, Chet R.; Hor, Kan N.; Jefferies, John L.; Gao, Zhiqian; Towbin, Jeffrey A.; Wong, Brenda L.; Mazur, Wojciech; Fleck, Robert J.; Sticka, Joshua J.; Benson, D. Woodrow; Taylor, Michael D.

In: Journal of the American Heart Association, Vol. 4, No. 4, e001338, 01.01.2015.

Research output: Contribution to journalArticle

Tandon, Animesh ; Villa, Chet R. ; Hor, Kan N. ; Jefferies, John L. ; Gao, Zhiqian ; Towbin, Jeffrey A. ; Wong, Brenda L. ; Mazur, Wojciech ; Fleck, Robert J. ; Sticka, Joshua J. ; Benson, D. Woodrow ; Taylor, Michael D. / Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy. In: Journal of the American Heart Association. 2015 ; Vol. 4, No. 4.
@article{4fba954bb39e47f8b9361bef0ad18ded,
title = "Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy",
abstract = "Background-Patients with Duchenne muscular dystrophy exhibit progressive cardiac and skeletal muscle dysfunction. Based onprior data, cardiac dysfunction in Duchenne muscular dystrophy patients may be influenced by myocardial fibrosis and steroidtherapy. We examined the longitudinal relationship of myocardial fibrosis and ventricular dysfunction using cardiac magneticresonance in a large Duchenne muscular dystrophy cohort.Methods and Results-We reviewed 465 serial cardiac magnetic resonance studies (98 Duchenne muscular dystrophy patientswith 7≥4 cardiac magnetic resonance studies) for left ventricular ejection fraction (LVEF) and presence of late gadoliniumenhancement (LGE), a marker for myocardial fibrosis. LVEF was modeled by examining LGE status, myocardial fibrosis burden (asassessed by the number of LGE-positive left ventricular segments), patient age, and steroid treatment duration. An age-only modeldemonstrated that LVEF declined 0.58±0.10{\%} per year. In patients with both LGE-negative and LGE-positive studies (n=51), LVEFdid not decline significantly over time if LGE was absent but declined 2.2±0.31{\%} per year when LGE was present. Univariatemodeling showed significant associations between LVEF and steroid treatment duration, presence of LGE, and number of LGEpositiveleft ventricular segments; multivariate modeling showed that LVEF declined by 0.93±0.09{\%} for each LGE-positive leftventricular segment, whereas age and steroid treatment duration were not significant. The number of LGE-positive left ventricularsegments increased with age, and longer steroid treatment duration was associated with lower age-related increases.Conclusion-Progressive myocardial fibrosis, as detected by LGE, was strongly correlated with the LVEF decline in Duchennemuscular dystrophy patients. Longer steroid treatment duration was associated with a lower age-related increase in myocardialfibrosis burden.",
keywords = "Cardiomyopathy, Magnetic resonance imaging, Morbidity",
author = "Animesh Tandon and Villa, {Chet R.} and Hor, {Kan N.} and Jefferies, {John L.} and Zhiqian Gao and Towbin, {Jeffrey A.} and Wong, {Brenda L.} and Wojciech Mazur and Fleck, {Robert J.} and Sticka, {Joshua J.} and Benson, {D. Woodrow} and Taylor, {Michael D.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1161/JAHA.114.001338",
language = "English (US)",
volume = "4",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy

AU - Tandon, Animesh

AU - Villa, Chet R.

AU - Hor, Kan N.

AU - Jefferies, John L.

AU - Gao, Zhiqian

AU - Towbin, Jeffrey A.

AU - Wong, Brenda L.

AU - Mazur, Wojciech

AU - Fleck, Robert J.

AU - Sticka, Joshua J.

AU - Benson, D. Woodrow

AU - Taylor, Michael D.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background-Patients with Duchenne muscular dystrophy exhibit progressive cardiac and skeletal muscle dysfunction. Based onprior data, cardiac dysfunction in Duchenne muscular dystrophy patients may be influenced by myocardial fibrosis and steroidtherapy. We examined the longitudinal relationship of myocardial fibrosis and ventricular dysfunction using cardiac magneticresonance in a large Duchenne muscular dystrophy cohort.Methods and Results-We reviewed 465 serial cardiac magnetic resonance studies (98 Duchenne muscular dystrophy patientswith 7≥4 cardiac magnetic resonance studies) for left ventricular ejection fraction (LVEF) and presence of late gadoliniumenhancement (LGE), a marker for myocardial fibrosis. LVEF was modeled by examining LGE status, myocardial fibrosis burden (asassessed by the number of LGE-positive left ventricular segments), patient age, and steroid treatment duration. An age-only modeldemonstrated that LVEF declined 0.58±0.10% per year. In patients with both LGE-negative and LGE-positive studies (n=51), LVEFdid not decline significantly over time if LGE was absent but declined 2.2±0.31% per year when LGE was present. Univariatemodeling showed significant associations between LVEF and steroid treatment duration, presence of LGE, and number of LGEpositiveleft ventricular segments; multivariate modeling showed that LVEF declined by 0.93±0.09% for each LGE-positive leftventricular segment, whereas age and steroid treatment duration were not significant. The number of LGE-positive left ventricularsegments increased with age, and longer steroid treatment duration was associated with lower age-related increases.Conclusion-Progressive myocardial fibrosis, as detected by LGE, was strongly correlated with the LVEF decline in Duchennemuscular dystrophy patients. Longer steroid treatment duration was associated with a lower age-related increase in myocardialfibrosis burden.

AB - Background-Patients with Duchenne muscular dystrophy exhibit progressive cardiac and skeletal muscle dysfunction. Based onprior data, cardiac dysfunction in Duchenne muscular dystrophy patients may be influenced by myocardial fibrosis and steroidtherapy. We examined the longitudinal relationship of myocardial fibrosis and ventricular dysfunction using cardiac magneticresonance in a large Duchenne muscular dystrophy cohort.Methods and Results-We reviewed 465 serial cardiac magnetic resonance studies (98 Duchenne muscular dystrophy patientswith 7≥4 cardiac magnetic resonance studies) for left ventricular ejection fraction (LVEF) and presence of late gadoliniumenhancement (LGE), a marker for myocardial fibrosis. LVEF was modeled by examining LGE status, myocardial fibrosis burden (asassessed by the number of LGE-positive left ventricular segments), patient age, and steroid treatment duration. An age-only modeldemonstrated that LVEF declined 0.58±0.10% per year. In patients with both LGE-negative and LGE-positive studies (n=51), LVEFdid not decline significantly over time if LGE was absent but declined 2.2±0.31% per year when LGE was present. Univariatemodeling showed significant associations between LVEF and steroid treatment duration, presence of LGE, and number of LGEpositiveleft ventricular segments; multivariate modeling showed that LVEF declined by 0.93±0.09% for each LGE-positive leftventricular segment, whereas age and steroid treatment duration were not significant. The number of LGE-positive left ventricularsegments increased with age, and longer steroid treatment duration was associated with lower age-related increases.Conclusion-Progressive myocardial fibrosis, as detected by LGE, was strongly correlated with the LVEF decline in Duchennemuscular dystrophy patients. Longer steroid treatment duration was associated with a lower age-related increase in myocardialfibrosis burden.

KW - Cardiomyopathy

KW - Magnetic resonance imaging

KW - Morbidity

UR - http://www.scopus.com/inward/record.url?scp=85012285866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012285866&partnerID=8YFLogxK

U2 - 10.1161/JAHA.114.001338

DO - 10.1161/JAHA.114.001338

M3 - Article

VL - 4

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 4

M1 - e001338

ER -